目的:探讨术前因素的影响,包括不同的瞳孔大小和屈光属性,关于接受植入式结晶体(ICL)植入的患者术后眩光障碍。
方法:第二附属医院,南昌大学,南昌,江西,中国。
方法:前瞻性观察性研究。
方法:分析了接受EVO-VisianICLV4c(VICMO)植入的合格患者的术前眼部特征和术后6个月的眩光状态。眩光失能标准包括眩光症状评分>6和眩光敏感度超过1:2.7。采用Logistic回归分析探讨术前眼部参数与ICL后眩光的关系。
结果:该研究包括95名患者(平均年龄,26.04±6.29年),包括30名男性(58眼)和65名女性(129眼)。多因素分析显示术后眩光障碍与术前近眼瞳孔球度增加之间存在显著相关性(β=-0.124,P=.039),以及术前中视瞳孔(β=-0.412,P=.009)和明视瞳孔(β=-0.430,P=.007)的圆柱功率升高。此外,术前瞳孔直径较大(β=0.561,P=0.005)与眩光障碍显著相关。
结论:术前近眼瞳孔尺寸和相关屈光参数,如球体和圆柱体,与眩光残疾相关,包括明视觉瞳孔的圆柱体方面,这可以帮助临床医生优化ICL植入的术前选择,帮助预测潜在的眩光残疾风险。
OBJECTIVE: To explore the influence of preoperative factors, including varying pupil sizes and refractive attributes, on postoperative glare disability in patients undergoing implantable collamer lens (ICL) implantation.
METHODS: Second Affiliated Hospital, Nanchang University, Nanchang, Jiangxi, China.
METHODS: Prospective observational study.
METHODS: The preoperative ocular characteristics and 6-month postoperative glare status in eligible patients who underwent EVO-Visian ICL V4c (VICMO) implantation were analyzed. The glare disability criteria encompassed a glare symptom score >6 and glare sensitivity exceeding 1:2.7. Logistic regression analysis was used to explore the relationship between the preoperative ocular parameters and post-ICL glare.
RESULTS: The study included 95 patients (mean age, 26.04 ± 6.29 years), comprising 30 men (58 eyes) and 65 women (129 eyes). Multivariate analysis revealed a significant correlation between postoperative glare disability and increased spherical power in preoperative mesopic pupils (β = -0.124, P = .039), as well as elevated cylinder power in preoperative mesopic (β = -0.412, P = .009) and photopic pupils (β = -0.430, P = .007). Moreover, a larger preoperative mesopic pupil diameter (β = 0.561, P = .005) demonstrated a significant correlation with glare disability.
CONCLUSIONS: Preoperative mesopic pupil dimensions and associated refractive parameters, such as sphere and cylinder, were correlated with glare disability, including the cylinder aspect in photopic pupils, which can assist clinicians in optimizing preoperative selection for ICL implantation, aiding in the anticipation of potential glare disability risks.